Real-world use of cefiderocol as monotherapy or combination therapy for the treatment of Gram-negative bacterial infections: the multicentre retrospective CEFI-BAC study.
Augello M, Di Bartolomeo F, Varisco B, Timelli L, Bartoletti M, Bonfanti P, Borghi F, Bruno R, Bussini L, Casari S, Cattelan AM, Cauda R, Codeluppi M, Cona A, Coppola N, Frallonardo L, Franzetti M, Fusco P, Garilli S, Gattuso G, Iaria C, Meschiari M, Monari C, Mularoni A, Mussini C, Piconi S, Pipitone G, Rizzi M, Rossi N, Rusconi S, Sanguinetti M, Saracino A, Scaglione V, Tagliaferri G, Torti C, Visicaro M, Marchetti G.
Augello M, et al. Among authors: fusco p.
Int J Infect Dis. 2026 Feb;163:108305. doi: 10.1016/j.ijid.2025.108305. Epub 2025 Dec 6.
Int J Infect Dis. 2026.
PMID: 41360217
Free article.